Newsroom Careers Contact Us

Partnership
with a Focus

Novugen Biz is a strategic Unit of Novugen focussing on creating synergies through B2B partnership with global healthcare and pharmaceutical companies.

Aligned with our vision to have a global footprint, we leverage on carefully selected collaborations to enhance our innovative and creative capabilities.

#Synergiesforsuccess

Building our
strength through
strategic partnership

Leveraging on our extensive experience, know-how, global product portfolio and state-of-the-art facilities, we offer a win-win proposition to create value for our partners, Additionally, we offer flexibility and speed to achieve greater success.

We work with partners to create new business opportunities, widen our product portfolio, leverage our R&D and manufacturing capabilities to better serve the well being of patients around the globe.

CONNECT WITH US TO CREATE SYNERGIES!

Our Strengths

GMP

Accreditations

200+

Professionals

70+

Generic Products In Pipeline

QUALITY

System Processes & People

PRODUCT APPROVAL

for US Market

Partnership Edge

Novugen Biz is a long-term partner of choice for most multinational companies, providing stable access to innovative therapy for patients.

32+

Partners

25+

Niche API

20+

Countries

200+

Scientists

70+

Complex FDF Portfolio

4

Global manufacturing facilities

Thank you for your interest in Novugen. To send inquiries, requests for info and feedback, simply fill out the form or write to us on bd@novugen.com

We respects your right to privacy while using our website. We collect and process persoal data that you provide in accordance with our data privacy policy.
Quick link

News And Company Insights

Explore latest news about us from across the globe.

NEWSROOM
Announcement of Company Name Change
Novugen 1st International Cardiometabolic and Urogynecology Summit (NICUS)
Official Product Launch and Distribution Partner Zuellig Pharma
Novugen Oncology Received the First ANDA Approval for Abiraterone 250mg and 500mg Tablets
Novugen Welcomes Deputy Chief Executive Officer of MIDA
Pioneering Novugen Pharma Vision in North America
Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand
Novugen Oncology Becoming the Largest and Fastest Growing Pharmaceutical Company in ASEAN by 2025
Novugen Oncology & Brightgene Bio-Medical Technology Announce Strategic Partnership to Enter U.S.A Pharma Market
Visit by The Deputy Minister of International Trade and Industry (MITI) and The Deputy Chief Executive Officer II of MIDA
Novugen Oncology Launches ASEAN’s First Oncology API R&D Centre